Ramius Advisors’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-51,912
Closed -$1.95K 4
2023
Q1
$1.95K Sell
51,912
-117,428
-69% -$6.6K ﹤0.01% 64
2022
Q4
$6.43K Buy
169,340
+45
+0% +$2 0.01% 77
2022
Q3
$11K Buy
169,295
+10,000
+6% +$905 0.01% 117
2022
Q2
$20K Buy
+159,295
New +$34.1K 0.01% 128
2021
Q4
Sell
-19,176
Closed -$12K 363
2021
Q3
$12K Buy
19,176
+8,976
+88% +$7.3K 0.01% 210
2021
Q2
$10K Buy
+10,200
New +$7.28K ﹤0.01% 275

Other funds holding COCHW

Ramius Advisors's COCHW Position: Q2 2023 in Review

Ramius Advisors sold out of Envoy Medical Warrant (COCHW) in Q2 2023, closing a stake of 51,912 shares — an estimated $1.95K sold.

Ramius Advisors first reported a position in COCHW in Q2 2021 and held it in 6 quarters. The position peaked at $20K in Q2 2022. 61 funds tracked by Wall St. Rank hold COCHW as of Q2 2023.

  • Ramius Advisors reported no remaining Envoy Medical Warrant position as of Q2 2023 after selling out during the quarter.
  • Ramius Advisors sold 51,912 Envoy Medical Warrant shares in Q2 2023, an estimated $1.95K.
  • Ramius Advisors first reported a position in Envoy Medical Warrant in Q2 2021 and held it in 6 quarters.
  • Ramius Advisors's Envoy Medical Warrant position peaked at $20K in Q2 2022.
  • 61 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q2 2023.

Based on Ramius Advisors's 13F filing for Q2 2023.